← Back to guidelines
Rheumatology1 paper

Pulmonary nematodiasis

Last edited: 4/15/2026

Overview

Pulmonary nematodiasis refers to infections caused by nematode parasites affecting the lungs, though the provided abstracts focus on abdominal angiostrongyliasis caused by Angiostrongylus costaricensis. This condition primarily involves intestinal vessels but can present with systemic manifestations that mimic other diseases including pulmonary involvement. 1

Diagnosis

  • Clinical presentation may include gastrointestinal symptoms and vascular complications.
  • Imaging studies (e.g., CT, MRI) can reveal bowel necrosis or vascular involvement.
  • Serological tests and stool examinations may identify the presence of Angiostrongylus larvae.
  • Histopathological examination of affected tissues is definitive for diagnosis. 1
  • Management

  • First-line treatment: Albendazole or mebendazole are typically recommended for nematode infections, though specific dosing for pulmonary involvement is not detailed in the abstracts.
  • Adjunctive care: Supportive measures including surgical intervention for bowel necrosis may be necessary.
  • Monitoring: Regular follow-up to assess resolution of symptoms and potential complications. 1
  • Special Populations

  • Pediatrics: Specific management considerations for pediatric patients are not addressed in the provided abstracts.
  • Elderly: No specific guidance for elderly patients is given.
  • Comorbidities: Management in patients with comorbidities like systemic vasculitides may require tailored approaches to differentiate from underlying conditions. 1
  • Key Recommendations

  • Consider abdominal angiostrongyliasis in the differential diagnosis for patients presenting with gastrointestinal symptoms and vascular complications, especially when systemic manifestations are present. (Evidence: Expert opinion 1)
  • Utilize imaging and histopathological examination for definitive diagnosis. (Evidence: Moderate 1)
  • Initiate treatment with albendazole or mebendazole, with close monitoring for complications requiring surgical intervention. (Evidence: Expert opinion 1)
  • References

    1 Palominos PE, Massignan A, Monticielo OA, Bortoli R, Kohem C, Cruz DB et al.. Abdominal angiostrongyliasis: what does the rheumatologist must know about it?. International journal of rheumatic diseases 2009. link

    Original source

    1. [1]
      Abdominal angiostrongyliasis: what does the rheumatologist must know about it?Palominos PE, Massignan A, Monticielo OA, Bortoli R, Kohem C, Cruz DB et al. International journal of rheumatic diseases (2009)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG